Empower Brands Proposes Acquisition of Helen of Troy Ltd.
Empower Brands proposes to acquire Helen of Troy Ltd. for $37 per share, a significant premium reflecting ongoing challenges for the company.
Petrobras updates schedule for Q3 2026 results webcast
Petrobras announces new date for Q3 2026 results webcast, set for November 11, 2026. The webcast will provide insights into the company's performance.
Novo Nordisk raises full-year outlook on strong Q3 results
Novo Nordisk A/S boosts its full-year outlook after a strong Q3, driven by GLP-1 sales. The company reports a 27% increase in adjusted operating profit.
Eagle Nuclear Energy signs LOI to acquire Noble Plains Uranium
Eagle Nuclear Energy Corp. has entered a letter of intent to acquire Noble Plains Uranium Corp., marking a significant move in the miscellaneous metal ores sector.
BrasilAgro Releases 2026/2027 Harvest Estimates
BrasilAgro announces its initial estimates for the 2026/2027 harvest year, showing a decrease in planted area and shifts in crop allocations.
Peabody Energy reports Q3 results, declares dividend
Peabody Energy Corp announces Q3 financial results with a net loss but improved adjusted EBITDA, alongside a quarterly dividend declaration.
XPEL Reports Q3 Revenue Growth of 9.9% to $137.8 Million
XPEL, Inc. announces Q3 2026 results with revenue growth of 9.9% to $137.8 million, reflecting strong performance in the Coating, Engraving & Allied Services industry.
Nest Egg ETFs Files 13F Notice for Q3 2026 Investment Update
Nest Egg ETFs LLC has submitted a 13F Notice detailing its investment activities as of September 30, 2026, signaling its strategy in the financial services sector.
Itaú Unibanco files 6-K detailing operational updates
Itaú Unibanco's recent 6-K filing provides insights into its operations and impacts on the state commercial banking sector.
Spectrum Brands Proposes Acquisition of Helen of Troy for $37/Share
Spectrum Brands proposes to acquire Helen of Troy for $37 per share, marking a strategic move in the miscellaneous electrical machinery sector.
NewAmsterdam Pharma reports Q3 2026 results, highlights progress
NewAmsterdam Pharma Co N.V. announces Q3 2026 results, showcasing advancements in drug development and financial performance.
Royalty Pharma reports strong Q3 results, raises guidance
Royalty Pharma plc announces a 9% increase in Q3 royalty receipts and raises its 2026 guidance, signaling strong growth in the pharmaceutical sector.
Madison Square Garden Entertainment Reports Strong Q1 Results
Madison Square Garden Entertainment Corp. announces a strong start to fiscal 2027 with a 37% revenue increase and significant share repurchases.
NCR Atleos Corp Reports Q3 Results, Highlights Growth Strategy
NCR Atleos Corp's Q3 report reveals financial metrics and strategic initiatives, impacting its position in the calculating and accounting machines industry.
NewAmsterdam Pharma reports financial statements in 8-K
NewAmsterdam Pharma Co N.V. files 8-K revealing financial statements, indicating transparency and potential impacts on stakeholders and competitors.
dLocal Ltd announces 2026 Annual General Meeting details
dLocal Ltd has scheduled its 2026 Annual General Meeting for December 2, focusing on governance and financial transparency.
Viridian Therapeutics reports Q3 2026 financial results
Viridian Therapeutics announces its Q3 2026 financial results, showcasing progress in pharmaceutical preparations amid a competitive landscape.
Seaport Therapeutics Director Acquires 5,000 Shares
Seaport Therapeutics' director Denice Torres acquires 5,000 shares, reflecting confidence in the company's future within the pharmaceutical preparations sector.
Dine Brands reports strong Q3 results, boosts revenue outlook
Dine Brands Global, Inc. reports growth in Q3 revenue and net income, signaling strength in the retail-eating places sector.
Rapport Therapeutics releases Q3 results, highlights growth
Rapport Therapeutics, Inc. shares its Q3 performance and future strategies in its latest filing, emphasizing growth in the pharmaceutical sector.